Top Analyst Actions: FMX, OCUL, LPLA, SUM, HSTM

FEMSA FMX HSBC Securities raises rating to hold from reduce

Ocular Therapeutix OCUL Morgan Stanley raises to overweight from equal-weight

LPL Financial LPLA Citigroup raises to neutral from sell

Summit Materials SUM Citigroup raises to buy from neutral

Healthstream HSTM Needham raises to buy from hold with $26.00 price target

ClearBridge Energy MLP Fund CEM BofA/Merrill lowers to neutral from buy

Salient Midstream & MLP Fund SMM BofA/Merrill lowers to neutral from underperform

Tortoise Pipeline & Energy Fund TTP BofA/Merrill lowers to neutral from underperform

Neuberger Berman MLP Income Fund (NYSE MKT: NML) BofA/Merrill lowers to neutral from underperform

Clearbridge Energy MLP TR Fund CTR BofA/Merrill lowers to neutral from underperform

T2 Biosystems TTOO WBB Securities initiates coverage at speculative buy with $11.00 price target

Memorial Resource Development MRD Iberia starts at sector perform

DSP Group DSPG Lake Street starts at buy with $10.00 price target

Whole Foods WFM Wells Fargo starts at market perform

Connecture CNXR First Analysis Sec starts at equal-weight with $8.00 price target

Mirati Therapeutics MRTX Jefferies resumes coverage at buy

Evoke Pharma EVOK FBR Capital resumes at outperform with $17.00 price target

Rackspace RAX UBS lowers price target to $19.00 from $28.00 with neutral rating

Nordstrom JWN UBS lowers price target to $58.00 from $63.00 with buy rating

InterActiveCorp IACI Axiom Capital lowers price target to $74.00 from $84.00 with buy rating

Community Health CYH Oppenheimer lowers price target to $35.00 from $43.00 with outperform rating

Imprivata IMPR Oppenheimer lowers price target to $16.00 from $17.00 with outperform rating